top of page

      News - Hephai  

picto-bulles-bleu.png

HEPHAï APPOINTS ARMELLE ROUSSAC AS HEAD OF SALES_ 06.2022

____

This appointment reinforces Hephaï leadership team as it prepares for CE marking of its application and partners with major pharmaceutical groups to make app available for asthma and COPD patients by end of 2022 

HEPHAÏ RECEIVES 2021 CATALYST AWARD FROM US NATIONAL ACADEMY OF MEDICINE_ 09.2021

____

$50k prize from US National Academy of Medicine recognizes Hephaï’s AI-based platform designed to help asthma and COPD (Chronic Obstructive Pulmonary Disease) patients

640px-Patented.jpg

HEPHAï FILES SOFTWARE PATENT FOR ITS DIGITAL EDUCATION PLATFORM_ 06.2021

____

This patent will allow Hephaï to protect its unique AI-based software for its educative platform - designed to help asthma and COPD patients avoid potential problems associated with incorrect inhaler use. 

logo_chiesi.png

HEPHAï PARTNERS WITH CHIESI _ 03.2021

____

Global pharmaceutical company Chiesi and Hephaï join forces to develop AI educational tool to improve inhaler use for asthma and COPD patients

bottom of page